Results 171 to 180 of about 46,855 (284)

Cervical Cancer Screening in HIV-Positive Women by Conventional Exfoliative Cytology and Liquid-Based Cytology. [PDF]

Cureus
Rai H, Verma D, Meena R, Uniya U, Nagayach N.   +4 more
europepmc   +1 more source

Empirical Osimertinib as a Second‐Line Treatment Is a Viable Option Following First‐ and Second‐Generation TKI Therapy With Unknown EGFR Status in Treated Non‐Small Cell Lung Cancer: A Retrospective Study

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background and Purpose Patients with advanced epidermal growth factor receptor (EGFR)‐mutated adenocarcinoma often receive frontline first‐ and second‐generation EGFR tyrosine kinase inhibitor (TKI) treatments in Taiwan. However, upon progression, not all patients undergo rebiopsy for molecular testing.
Min‐Hsi Lin, Kuo‐An Chu, Chiu‐Fan Chen, You‐Cheng Jiang, Wei‐Cheng Hong, Ming‐Yen Hung, Chun‐Hsiang Hsu   +6 more
wiley   +1 more source

Evaluation of targeted next-generation sequencing for detection of HPV genotypes and sublineages in cervical liquid-based cytology SurePath samples from the Danish screening program. [PDF]

Int J Cancer
Andersen K, Bonde J, Waldstrøm M, Jakobsen MV, Lamy P, Pedersen H, Bønløkke S, Stougaard M, Steiniche T.   +8 more
europepmc   +1 more source

Identification of Prognostic Risk Factors in Older Patients With Extensive‐Stage Small Cell Lung Cancer

Cancer Medicine, Volume 15, Issue 5, May 2026.
The study corroborates the prognostic value of previously identified risk factors impacting progression‐free survival (PFS) and overall survival (OS) in older patients with extensive‐stage small cell lung cancer (ES‐SCLC). The figure was created with Microsoft PowerPoint.
Jiayin Liu, Xun Liu, Xiaolin Li, Ning Liu, Bo Wang, Li Feng, Zhisong Fan, Long Wang, Jing Han, Xue Zhang, Hui Jin, Dan Li, Yan Liu, Jing Zuo, Yudong Wang   +14 more
wiley   +1 more source

Deep learning enabled liquid-based cytology model for cervical precancer and cancer detection. [PDF]

Nat Commun
Xue P, Dang L, Kong LH, Tang HP, Xu HM, Weng HY, Wang Z, Wei RG, Xu L, Li HX, Niu HY, Wang MJ, Ye ZC, Li ZF, Chen W, Pan QJ, Zhang X, Rezhake R, Zhang L, Jiang Y, Qiao YL, Zhu L, Zhao FH.   +22 more
europepmc   +1 more source

The Efficiency of Cervical Pap and Comparison of Conventional Pap Smear and Liquid-Based Cytology: A Review. [PDF]

Cureus, 2023
Dasgupta S.
europepmc   +1 more source

Ultrarapid BRAF mutation detection on supernatant cell‐free DNA obtained by FNA: An accurate and expedient method for BRAF assessment in aggressive thyroid carcinomas

Cancer Cytopathology, Volume 134, Issue 5, May 2026.
Abstract Background For patients with aggressive thyroid cancer, including anaplastic thyroid carcinoma (ATC) and high‐grade follicular cell‐derived non‐anaplastic thyroid carcinoma, rapid BRAF p.V600E testing is critical as targeted therapy with BRAF/MEK inhibitors significantly improves outcomes.
Jose Manuel Gutierrez Amezcua, Maria E. Arcila, Dianna L. Ng, Rusmir Feratovic, Khawaja Hasan Bilal, Jean Marc Cohen, Xiao‐Jun Wei, Brie Kezlarian‐Sachs, Carlie S. Sigel, Narasimhan Agaram, Khedoudja Nafa, Paulo Salazar, Oscar Lin, David Kim   +13 more
wiley   +1 more source

The morphological characteristics and arrangements of cells in the liquid-based cytology preparation of patients with endometrial lesions. [PDF]

Diagn Pathol
Wu MZ, Gu NJ, Xiao MM, Liu DG, Jin ML, Liu XY, Wang J, Xu HT, Zhang Y, Wu GP.   +9 more
europepmc   +1 more source

Identification of cancer driver mutations in liquid-based cytology samples for the screening of endometrial diseases. [PDF]

BJC Rep, 2023
Matsuura M, Takane K, Yamaguchi K, Ikenoue T, Hatakeyama S, Kurokawa S, Tamate M, Akimoto T, Iwasaki M, Sugita S, Hasegawa T, Ota Y, Saito T, Furukawa Y.   +13 more
europepmc   +1 more source

Pap testing and high‐risk HPV testing for women aged 65 years and older with surgical pathology follow‐up

Cancer Cytopathology, Volume 134, Issue 5, May 2026.
ABSTRACT Background Current professional guidelines recommend discontinuing Papanicolaou (Pap) test screening in women aged 65 years and older who have had adequate prior negative testing. However, limited data exist on Pap test performance and histologic outcomes in this population.
Timothy G. Ramseyer, Bethany Batson, Daisy Wu, Jonee L. Matsko, Amy K. Colaizzi, Samer N. Khader, Chengquan Zhao   +6 more
wiley   +1 more source